Molecular Imaging Market Size, Share, Future Analysis, 2026-2034

Market Overview

According to fortune business insights, the global molecular imaging market size was valued at USD 2.32 billion in 2025. The market is projected to grow from USD 2.45 billion in 2026 to USD 3.92 billion by 2034, exhibiting a CAGR of 6.05% during the forecast period. North America dominated the molecular imaging market with a market share of 43.69% in 2025.

The analysis shows that the market is driven by the growing prevalence of chronic conditions such as cancer, neurological disorders, and cardiovascular diseases, which increases the demand for advanced diagnostic procedures. For instance, the National Cancer Institute (NCI) estimated that about 2.0 million new cancer cases would be diagnosed in the U.S. in 2024. Key players are focusing on R&D to introduce innovative products, such as advanced PET scanners, to meet this growing demand.

Major Players Profiled in the Market Report:

• GE Healthcare (U.S.)

• Siemens Healthineers AG (Germany)

• Koninklijke Philips N.V. (Netherlands)

• Shimadzu Corporation (Japan)

• CANON MEDICAL SYSTEMS CORPORATION (Japan)

• Bruker (U.S.)

• Lantheus Holdings, Inc. (U.S.)

• Segami Corporation (U.S.)

Segments

Growing Adoption of PET Scanners to Drive Segment GrowthBased on type, the market is classified into Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and others. The PET segment dominated the market, driven by the increasing prevalence of neurological disorders, a growing emphasis on early disease detection, and an expanding installed base of PET scanners globally.

Increasing Cancer Prevalence to Boost Oncology Segment GrowthBy application, the market is divided into cardiology, oncology, orthopedics, gynecology, neurology, and others. The oncology segment held the dominant market share due to the rising prevalence of various cancers and a growing diagnosis rate, which drives the demand for advanced imaging in cancer care.

Shift in Patient Preference to Drive Diagnostic Imaging Centers SegmentBased on end-user, the market is segmented into hospitals, specialty clinics, diagnostic imaging centers, and others. The diagnostic imaging centers segment is expected to grow with a considerable CAGR, fueled by a shift in patient preference toward these centers for their convenience, easy accessibility, and reduced waiting times.

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

For detailed market insights: https://www.fortunebusinessinsights.com/molecular-imaging-market-112879

Report Coverage

The report offers:

• Major growth drivers, restraining factors, opportunities, and potential challenges for the market.

• Comprehensive insights into regional developments.

• List of major industry players.

• Key strategies adopted by the market players.

• The latest industry developments, including new product launches, partnerships, mergers, and acquisitions.

Drivers & Restraints

Increasing Prevalence of Chronic Disorders to Augment Product DemandThe growing prevalence of chronic disorders, including Alzheimer’s disease, cancer, and heart disease, is a primary market driver. A rising geriatric population and lifestyle changes are contributing to an increase in these conditions, leading to a greater number of patients requiring accurate diagnosis and treatment, thereby boosting the demand for molecular imaging products.

However, the high cost associated with molecular imaging equipment may limit market expansion. The price of new PET/CT scanners can range from USD 0.5 million to over USD 5.0 million. This high cost can be a significant barrier to adoption, especially for smaller healthcare facilities and in lower-income countries.

Regional Insights

Strong Healthcare Infrastructure Propels Market Growth in North AmericaNorth America holds the dominant molecular imaging market share. The region’s growth is attributed to high per capita healthcare expenditure, advanced healthcare infrastructure, favorable reimbursement policies, and the presence of key players introducing innovative devices.

Asia Pacific is projected to be the fastest-growing region in the market. This growth is driven by an increasing geriatric population, a large patient pool, developing healthcare infrastructure, and strategic activities by key players to strengthen their presence in countries like China and India.

Molecular Imaging Market Future Growth

The molecular imaging market is advancing rapidly, with a strong trend toward technologically sophisticated devices. There is a clear preferential shift toward hybrid imaging systems such as PET/CT and SPECT/CT, which offer superior image quality, faster results, and improved diagnostic accuracy for chronic conditions. This trend aligns with the broader move toward personalized medicine, as molecular imaging provides detailed insights into individual disease characteristics, facilitating tailored treatment strategies. Future growth will be fueled by continued innovation, including AI-powered capabilities, that enhance diagnostic precision and patient outcomes.

Competitive Landscape

Introduction of New Products by Key Players Drives Market DominanceThe global market is consolidated, with companies such as GE Healthcare, Siemens Healthineers AG, and Koninklijke Philips N.V. accounting for a significant share. These industry leaders maintain their position through robust global distribution networks, a strong focus on new product launches, and strategic mergers, acquisitions, and partnerships. Their continuous R&D efforts and expansion into emerging markets are key to sustaining market momentum.

Key Industry Development

• October 2024: GE Healthcare launched a new SPECT/CT Aurora with AI-powered capabilities to expand its presence in Europe.

• October 2024: Siemens Healthineers AG collaborated with University Hospital Nantes (CHU de Nantes) to advance innovation in diagnostic and interventional imaging in France.

• September 2024: Shimadzu Corporation expanded its subsidiary for medical systems in Mexico, strengthening its presence in the LATAM region.

Uncover Japan’s Market Trends - Explore the Latest Molecular Imaging Market Insights